Not available
Quote | Onconova Therapeutics Inc. (NASDAQ:ONTX)
Last: | $0.9953 |
---|---|
Change Percent: | 0.0% |
Open: | $1 |
Close: | $0.9953 |
High: | $1 |
Low: | $0.7655 |
Volume: | 1,249,487 |
Last Trade Date Time: | 04/02/2024 03:00:00 am |
News | Onconova Therapeutics Inc. (NASDAQ:ONTX)
2024-04-02 14:02:10 ET More on Onconova Therapeutics Seeking Alpha’s Quant Rating on Onconova Therapeutics Historical earnings data for Onconova Therapeutics Financial information for Onconova Therapeutics Read the full article on Seeking Alpha ...
NEWTOWN, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (Nasdaq: TRAW, “Traws”, the “Company”) today announced it has granted equity awards to new employees who joined Traws in connection with the recent acquisition of Trawsfynydd Therapeutics, Inc. by Onco...
Message Board Posts | Onconova Therapeutics Inc. (NASDAQ:ONTX)
Subject | By | Source | When |
---|---|---|---|
shalbyj: TheStreetReports: AI Biotech Stocks to Watch 2023: $IPA, $ONTX, $AGEN, $PBIO https://www.ma | shalbyj | investorshangout | 04/25/2023 1:35:53 PM |
znewcar1: $ONTX 55% v23,3M c1.09 f20,969M H1.24 ML.65 GapNheld .8 | znewcar1 | investorshangout | 04/22/2023 3:01:39 AM |
whytestocks: $ONTX News Article - Penny Stocks To Buy Now? 5 With Big News Today | whytestocks | investorshangout | 04/21/2023 2:35:46 PM |
whytestocks: $ONTX News Article - Onconova Therapeutics Announces the Presentation of New Preclinica | whytestocks | investorshangout | 04/19/2023 3:05:46 PM |
whytestocks: $ONTX News Article - Onconova Therapeutics and Pangea Biomed Enter into Research Collab | whytestocks | investorshangout | 03/23/2023 4:10:54 PM |
News, Short Squeeze, Breakout and More Instantly...
Onconova Therapeutics Inc. Company Name:
ONTX Stock Symbol:
NASDAQ Market:
Onconova Therapeutics Inc. Website:
Closing cash balance of approximately $28 million expected from concurrent private placement led by OrbiMed and Torrey Pines Funding expected to ...
NEWTOWN, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (Nasdaq: TRAW, “Traws”, the “Company”) today announced it has granted equity awards to new employees who joined Traws in connection with the recent acquisition of Trawsfynydd Therapeutics, Inc. by Onco...
Closing cash balance of approximately $28 million expected from concurrent private placement led by OrbiMed and Torrey Pines Funding expected to advance development of three potential best-in-class/class leading assets: viroksavir, a cap-dependent endonuclease inhibitor for influenza; tra...